Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Ungaro

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|February 22, 2017
Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database StudyPriti Poojary, Aparna Saha, Kinsuk Chauhan, et al.
Global Heart|February 19, 2015
Point-of-Care Ultrasound and the Rapid Response SystemDaniel J Lakoff, Maya H Barghash, Scott Lorin, et al.
The American Journal of Gastroenterology|November 6, 2020
Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD RegistryJoseph W Windsor, Fox E Underwood, Erica Brenner, et al.
Digestive Diseases and Sciences|January 5, 2019
Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel DamageHinaben Panchal, Mathilde Wagner, Manjil Chatterji, et al.
Contemporary Clinical Trials|November 19, 2025
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trialLaurie Keefer, Ryan Ungaro, Ayanna Lewis, et al.
The American Journal of Gastroenterology|March 13, 2025
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 StudyScott D Lee, Severine Vermeire, Ryan Ungaro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2021
Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and OpioidsLaurie Keefer, Ksenia Gorbenko, Tina Siganporia, et al.
The American Journal of Gastroenterology|September 17, 2014
Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysisRyan Ungaro, Charles N Bernstein, Richard Gearry, et al.
Digestive Diseases and Sciences|January 1, 2021
Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBDAdam S Faye, Timothy Wen, Ali Soroush, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease ProgressionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|February 22, 2017
Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database StudyPriti Poojary, Aparna Saha, Kinsuk Chauhan, et al.
Global Heart|February 19, 2015
Point-of-Care Ultrasound and the Rapid Response SystemDaniel J Lakoff, Maya H Barghash, Scott Lorin, et al.
The American Journal of Gastroenterology|November 6, 2020
Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD RegistryJoseph W Windsor, Fox E Underwood, Erica Brenner, et al.
Digestive Diseases and Sciences|January 5, 2019
Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel DamageHinaben Panchal, Mathilde Wagner, Manjil Chatterji, et al.
Contemporary Clinical Trials|November 19, 2025
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trialLaurie Keefer, Ryan Ungaro, Ayanna Lewis, et al.
The American Journal of Gastroenterology|March 13, 2025
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 StudyScott D Lee, Severine Vermeire, Ryan Ungaro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2021
Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and OpioidsLaurie Keefer, Ksenia Gorbenko, Tina Siganporia, et al.
The American Journal of Gastroenterology|September 17, 2014
Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysisRyan Ungaro, Charles N Bernstein, Richard Gearry, et al.
Digestive Diseases and Sciences|January 1, 2021
Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBDAdam S Faye, Timothy Wen, Ali Soroush, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease ProgressionNeeraj Narula, Emily C L Wong, Parambir S Dulai, et al.
Pageof 7